The PE Ratio as of November 2024 (TTM) for InVitro International (IVRO) is -0.82

According to InVitro International’s latest financial reports and current stock price. The company's current PE Ratio is -0.82. This represents a change of -106.14% compared to the average of 13.35 of the last 4 quarters.

InVitro International (IVRO) Historical PE Ratio (quarterly & annually)

How has IVRO PE Ratio performed in the past?

The mean historical PE Ratio of InVitro International over the last ten years is 107.68. The current -0.82 PE Ratio has changed -176.15% with respect to the historical average. Over the past ten years (40 quarters), IVRO's PE Ratio was at its highest in in the December 2021 quarter at 24.98. The PE Ratio was at its lowest in in the September 2021 quarter at -553.37.

InVitro International (IVRO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of InVitro International PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InVitro International (IVRO) Average PE Ratio

How has IVRO PE Ratio performed in the past?

The current PE Ratio of InVitro International (IVRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

InVitro International (IVRO) PE Ratio vs. Peers

How is IVRO’s PE Ratio compared to its peers?

InVitro International’s PE Ratio is greater than Izotropic Corporation (-1.44), greater than Biodesix, Inc. (-4.67), less than Neuronetics, Inc. (-0.66), greater than Star Equity Holdings, Inc. (-1.42), less than Burning Rock Biotech Limited (-0.48), greater than DarioHealth Corp. (-4.24), less than Genetron Holdings Limited (0), greater than Sera Prognostics, Inc. (-6.70), greater than Olink Holding AB (publ) (-96.25), greater than Exagen Inc. (-3.13), greater than VolitionRx Limited (-2.12), less than Intelligent Bio Solutions Inc. (-0.23), greater than bioAffinity Technologies, Inc. (-1.95), greater than SeqLL Inc. (-4.58), less than HTG Molecular Diagnostics, Inc. (-0.02), less than T2 Biosystems, Inc. (-0.22), less than Biocept, Inc. (-0.01), less than iSpecimen Inc. (-0.31),

Build a custom stock screener for InVitro International (IVRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InVitro International using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InVitro International (IVRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InVitro International or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.